ARCHIVES

CCOPs Favor Ability To Enter Patients On Any Group Study

This article is from The Cancer Letter archive.

Vol. 24 No. 23 | June 12, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored

October 26, 1990

Complete List of Recommendations by Centers Committee

October 18, 1996

Program Project Guidelines Listed

March 18, 1977